{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 477374938
| IUPAC_name = (''RS'')-1-[2-[3-(''tert''-butylamino)-2-hydroxypropoxy]-5-fluorophenyl]butan-1-one
| image = Butofilolol skeletal.svg

<!--Clinical data-->
| tradename = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status = 
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 64552-17-6
| CAS_supplemental = 
| ATC_prefix = none
| ATC_suffix = 
| ATC_supplemental = 
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 157443
| PubChem = 68838
| IUPHAR_ligand = 
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = 
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 4AZC6Y5A8G
| synonyms = CM-6805
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 62071

<!--Chemical data-->
| chemical_formula = 
| C=17 | H=26 | F=1 | N=1 | O=3 
| molecular_weight = 311.392 g/mol
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C17H26FNO3/c1-5-6-15(21)14-9-12(18)7-8-16(14)22-11-13(20)10-19-17(2,3)4/h7-9,13,19-20H,5-6,10-11H2,1-4H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = NMBNQRJDEPOXCP-UHFFFAOYSA-N
| smiles = Fc1ccc(OCC(O)CNC(C)(C)C)c(c1)C(=O)CCC
}}

'''Butofilolol''' (trade name '''Cafide''') is a [[beta-blocker]] drug for the treatment of [[essential hypertension]] (high blood pressure).<ref>{{Cite journal 
| last1 = Houin 
| first1 = G 
| last2 = Barre 
| first2 = J 
| last3 = Jeanniot 
| first3 = JP 
| last4 = Ledudal 
| first4 = P 
| last5 = Cautreels 
| first5 = W 
| last6 = Tillement 
| first6 = JP 
| title = Pharmacokinetics of butofilolol (CAFIDE) after repeated oral administration in man 
| journal = International journal of clinical pharmacology research 
| volume = 4 
| issue = 3 
| pages = 175–83 
| year = 1984 
| pmid = 6149195
}}</ref><ref>{{Cite journal 
| last1 = Toussain 
| first1 = P 
| last2 = Gay 
| first2 = G 
| last3 = Debry 
| first3 = G 
| title = Long-term hypotensive treatment by butofilolol 
| journal = Annales de cardiologie et d'angeiologie 
| volume = 32 
| issue = 4 
| pages = 277–83 
| year = 1983 
| pmid = 6412614
}}</ref> It is not known to be marketed anywhere.

== References ==
{{reflist}}

{{Adrenergics}}

[[Category:Beta blockers]]


{{antihypertensive-stub}}